Autoimmune Technologies, LLC

New Orleans, LA 70112

SBIR Award Summary

Total Number of Awards 8
Total Value of Awards $5.19MM
First Award Date 02/01/97
Most Recent Award Date 06/15/14

Key Personnel

Last Name Name Awards Contact
Wilson Russell B Wilson 4
Kulakosky Peter Charles Kulakosky 1
Garry Robert F Garry 2
HOPKINS SAMUEL EARL HOPKINS 1

8 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-234
Budget: 06/15/14 - 05/31/15

DESCRIPTION (provided by applicant): The broad long-term objectives of the proposed work are to develop effective medical countermeasures to be used for the treatment of viral infectious disease caused by exposure to human coronaviruses. The work will focus on the discovery and development of peptide-based therapeutics for the treatment of perso...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/01/11 - 08/31/13

DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medical conditions can develop post-flu pneumonia and other lethal complications. The causative a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 09/01/10 - 08/31/11

DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medical conditions can develop post-flu pneumonia and other lethal complications. The causative a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-08-050
Budget: 06/10/09 - 08/31/10

DESCRIPTION (provided by applicant): Between 10% and 20% of the United State population suffer from seasonal influenza each year. While most individuals recover from influenza in one to two weeks, the very young, the elderly and persons with chronic medical conditions can develop post-flu pneumonia and other lethal complications. The causative a...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/07 - 07/31/08

DESCRIPTION (provided by applicant): Influenza virus is 1 of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID Biodefense Category C priority pathogen, a status that may be upgraded due to the recent emergence of a highly virulent strain of avian influenza vir...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PAS-02-149
Budget: 08/01/06 - 07/31/07

DESCRIPTION (provided by applicant): Influenza virus is 1 of the most important human pathogens accounting for widespread morbidity and mortality. Influenza virus is currently classified as a NIAID Biodefense Category C priority pathogen, a status that may be upgraded due to the recent emergence of a highly virulent strain of avian influenza vir...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 03/15/06 - 02/28/08

DESCRIPTION (provided by applicant): We aim to produce a significantly improved diagnostic system for autoimmune, rheumatologic disease. Similarities between autoimmune diseases and HIV-induced diseases led us to look for a retrovirus involved in autoimmune disease. We found a retrovirus, human intracisternal A-type particle (HIAP), in Sjogren's...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/97 - 07/31/97

The long-term goal is to demonstrate that the Anti-Polymer Antibody Assay is diagnostic for chronic fatigue syndrome patients and fibromyalgia patients. In a pilot study 55 % (6/11) of chronic fatigue syndrome patient sera, 71 % (12/17) of fibromyalgia patient sera and 9 % (1/11) sera from healthy norma...